{"nct_id":"NCT03965533","title":"Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2831781 After an Intravenous (IV) Dose in Healthy Japanese and Caucasian Subjects, and a Subcutaneous (SC) Dose in Healthy Caucasian Subjects","status":"COMPLETED","status_verified_date":"2020-09","start_date":"2019-06-10","start_date_type":"ACTUAL","primary_completion_date":"2019-12-10","primary_completion_date_type":"ACTUAL","completion_date":"2019-12-10","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}